Commentary
Pharmacology of Ethaverine HC1 Human and Animal Studies
Abstract
The pharmacology of ethaverine hydrochloride has been studied in humans and animals. The studies determined that the drug was an effective smooth muscle relaxant. The ethaverine hydrochloride produced significant increase in peripheral blood flow in patients with occlusive artery disease. In longitudinal studies there was no evidence of toxic effects in patients receiving 100 mg ethaverine HCI three times a day.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
